CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Clinical trial NCT05854966 · WITHDRAWN

Trial details

NCT number: NCT05854966
Sponsor: Wake Forest University Health Sciences
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia Refractory Granulocytic Sarcoma

Start date: 2024-12-01
Primary completion: 2025-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.